

Future of Beauty: A Chemist Predicts The Next Niacinamide, What The Beauty Biz Change-Makers Are Banking On Now and The Reason “Inflammaging” Will Be The Word on Everyone’s Lips This Year
Jan 8, 2025
Joshua Britton, scientist and CEO of Debut Biotech and Dende Skincare, dives into the future of beauty with a focus on biotech-driven skincare solutions. He explains the intriguing concept of "inflammaging" and how it affects skin health. Discover the powerhouse polyphenol, naringenin, which could be 15 times more effective than niacinamide. Joshua also discusses the potential shift towards longevity skincare and the impact of biotechnology on the beauty industry, including sustainable and vegan formulations.
AI Snips
Chapters
Transcript
Episode notes
Beauty's Pull
- Joshua Britton, Dende's CEO, wasn't initially in the beauty industry.
- His background in chemistry and creating molecules led him to beauty because of its innovative nature.
Science-Led Approach
- Dende focuses on product innovation, not just marketing.
- They prioritize scientific backing with preclinical and clinical data for new ingredients, setting a high bar.
Inflamaging Defined
- "Inflamaging" combines anti-inflammatory and anti-aging.
- It addresses the root causes of aging, making it more preventative than traditional anti-aging.